Status and phase
Conditions
Treatments
About
This is a double-blind randomized controlled trial evaluating the effect of perioperative dual bronchodilator therapy on post-operative pulmonary function and health-related quality of life (QoL) in mild-to-moderate less symptomatic COPD patients undergoing lung cancer surgery.
Investigators hypothesized that dual bronchodilator, as compared with placebo, would prevent reduction of pulmonary function after surgical resection and improve postoperative health related QoL.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subjects of men or female over 40 years of age who are scheduled for curative pulmonary lobectomy due to confirmation (or high suspicion) of non-small cell lung cancer (NSCLC)
Subjects waiting at least 14 days for scheduled pulmonary lobectomy
Subjects who are newly diagnosed with COPD* or who have not used any bronchodilators within the past 3 months, even if they have previously been diagnosed with COPD
Subjects with dyspnea of 0 or 1 grade measured by modified Medical Research Council (mMRC)
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
204 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Hye Yun Park, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal